Abstract
Patients with MM have a high risk of VTE. The relationship between MM and ATE is less clear. In this issue of Blood, Libourel and colleagues report a high incidence of ATE in MM patients undergoing chemotherapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2-3 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 116 |
| Issue number | 1 |
| DOIs |
|
| State | Published - Jul 8 2010 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology